By reprogramming a 7–year–old girl’s own immune cells to attack an aggressive form of childhood leukemia, a pediatric oncologist has achieved a complete response in his patient, who faced grim prospects when she relapsed after conventional treatment. The innovative experimental therapy used bioengineered T cells, custom–designed to multiply rapidly in the patient, and then destroy leukemia cells. After the treatment, the child’s doctors found that she had no evidence of cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/50777-chop-engineered-immune-t-cell-therapy-anticancer-effect-in-children
The University of Texas Health Science Center at Houston (UTHealth) has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child’s own umbilical cord blood stem cells for traumatic brain injury in children. The study is being performed in conjunction with Children’s Memorial Hermann Hospital, UTHealth’s primary children’s teaching hospital.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cordblood/48021/
Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss
Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world’s largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child’s own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57707-cord-blood-registry-stem-cell-trials-child-autism
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
Bad dietary habits and modern sedentary lifestyles have converged to create a worldwide epidemic that is constantly increasing: obesity (BMI > 30).
One billion adults around the world and twenty-two million children under the age of 5 are overweight.
Faced with this problem, LPG wanted to study the effect of LPG® mechano stimulation on fat cells to obtain proven results of the impact of Cellu M6® on localised areas of fat.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/lpg/50526/
The bold and thrilling quest to finally understand the brain—and along with it our mental afflictions, from depression to autism—by a rising star in neuroscience
Sebastian Seung, a dynamic young professor at MIT, is at the forefront of a revolution in neuroscience. He believes that our identity lies not in our genes, but in the connections between our brain cells—our own particular wiring. Seung and a dedicated group of researchers are leading the effort to map these connections, neuron by neuron, synapse by synapse. It is a monumental effort—the scientific equivalent of climbing Mount Everest—but if they succeed, they will uncover the basis of personality, identity, intelligence, memory, and perhaps disorders such as autism and schizophrenia. Seung explains how this new map of a human “connectome” might even enable us to “upload” our brains into a computer, making us effectively immortal.
Connectome is a mind-bending adventure story, told with great passion and authority. It presents a daring scientific and technological vision for at last understanding what makes us who we are, both as individuals and as a species. Find out more here, http://bit.ly/yEBoyq Non-Fiction
USANA Health Sciences is pleased to announce an innovative technological advancement: its U.S. patent-pending USANA InCelligence Technology™. This exclusive cell-signaling technology—now found in various USANA® products—is designed to help your body’s cells renew and protect themselves in unique and powerful ways, representing a monumental leap forward in cellular nutrition and overall wellness.*
“USANA continues to build a reputation as an innovator in the science of cellular health and nutritional supplementation,” says USANA Founder Dr. Myron Wentz. “With USANA’s InCelligence Technology, we are ensuring that our company remains on the cutting-edge of nutritional supplementation.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7736551-usana-incelligence-technology/
The YOU Consulting Group has highly skilled professionals, certified in The Knowledge of YOU, that can resolve many of the challenges associated with raising children. Call today to begin enjoying the benefits of having children. Toll Free 1-800-517-9384
Unfortunately, as Graham is adopted, he doesn\\\'t have an HLA-identical sibling to act as a donor for him. So the Red Cross here in Australia searched the Bone Marrow Registries worldwide for 9 months to find a match.
Graham has a rare tissue type and a match was not found.
Thanks to generous donations of over $400,000, Graham was able to travel from his home in Melbourne, Australia to Seattle in the USA for a revolutionary, life-saving stem cell treatment in April 2008.
On Wed 6th August, he was the 8th person in the world to receive a Stem Cell Transplant using stem cells grown in the lab from an umbilical cord.
The treatment was a complete success and he is now leukaemia free.
He is back in Melbourne, recovering from the treatment but still has outstanding medical bills of $416,000.
Tony tells us how he totally removed the pre cancerous Actinic Keratosis from his FACE at home in only 14 DAYS using www.Ag3derm.com cream he applied the cream 2 x times Daily and the abnormal cells were destroyed leaving fresh new pink skin that slowly blended in withhis surrounding skin.
Permeable or not, this is in the case of glass, in fact the question. Light shines through, this is what most people think, however, this is not quite true. Low iron glass is aimed to protect cells, but it is supposed to also let more light energy shine on the modules than normal window glass. On the other hand, modern three-or four-glazed windows let light through, but form an energy-saving temperature barrier. This way in the winter the cold stays outside and the heat inside. In the summer modern windows can automatically darken and prevent the room from heating up - energy for air conditioning is therefore saved. Glass has a lot of potential, a fact the visitors to the trade fairs glasstec and solarpeq in Düsseldorf, will have the chance to convince themselves of.
